To combat allegations of political interference — which may have impacted HHS’ response to the COVID-19 pandemic — HHS agencies, including the FDA, are updating their scientific integrity policies and implementing new safeguards to protect against such interference, says a new report from the Government Accountability Office (GAO) issued Thursday.
Source: Drug Industry Daily